Science Market Update

Michigan Researchers: Over $2 Billion in R&D

Posted by Andrea Inks on Thu, Feb 07, 2019

 

Read More

Tags: Trade show, Michigan State, Research Event, University of Michigan research, U of M retirement study, Zombie cells

UCLA Researchers Design a Renewable Source of Cancer Fighting T Cells

Posted by Andrea Inks on Mon, Jan 28, 2019

Read More

Tags: Ucla Research Vendors, UCLA, life science research at UCLA, UCLA research funding, UCLA stem cells

15.4M in NIH Grants at UPENN’s ACC

Posted by Andrea Inks on Tue, Jan 08, 2019

With  a new $15.4M NIH grant, The Abramson Cancer Center will continues to build on its significant historical strengths in fundamental cancer biology, translational immunotherapy, and population science research.

Read More

Tags: UPenn, NIH funding, NIH grant, Cancer Science

UGA receives  $10M Grant to Create Computational And Informatics Tools for Glycoscience

Posted by Andrea Inks on Thu, Jan 03, 2019

The $10M grant, which was given jointly to The University of Georgia, Athens and George Washington University, will be used to build a glycoscience informatics portal, called GlyGen. This portal is essential for glycoscience to advance. GlyGen will also incorporate glycan data with gene and protein data, to allow for greater analysis.

Read More

Tags: University of Georgia Athens, UGA, NIH grant, Glycoscience, GlyGen

Utah’s Department of Bioengineering Spends $17M Annually on Research and Produces Breakthrough in 3D Bioprinting

Posted by Rebecca Inch-Partridge on Fri, Dec 28, 2018

The University of Utah is recognized as a Top-Tier 1 research university by the Carnegie Classification of Institutions in Higher Education. According to the Vice President of Research the University was awarded 2,326 grants in 2018 and had $515 million in research funding. According to the National Institutes of Health, the university received $152,843,112 from them this year.

Read More

Tags: Utah, University of Utah Salt Lake City, Univ of Utah, BioResearch Product Faire™, 3D Printing and Medical Devices, university research funding, 3D bioprinting

University of Kansas Uses $25M NIH Grant to fund Multiple Research Projects

Posted by Gloria Beverage on Thu, Dec 20, 2018

Thanks to a five-year, $25 million grant, the largest given to the University of Kansas by the National Institutes of Health (NIH), several campus research projects have been funded to promote research development in high priority areas.

Read More

Tags: Midwest, Leukemia, Kansas, University of Kansas, Research Funding

Washington U. St. Louis Receives $20M Gift & $14.5M in Grant Funding

Posted by Gloria Beverage on Thu, Dec 13, 2018

 

Read More

Tags: Washington University St. Louis, Bioresearch funding, Biotechnology vendor show, Washington University, WUSTL, BioResearch Product Faire, Birth Defects, Pediatric Neurology, Translational Science

NIH awards $11.5 Million Grant to The University of Utah

Posted by Andrea Inks on Tue, Dec 11, 2018

The NIH awarded $11.5 million grant to The University of Utah to Study Sarcomagenesis.

Read More

Tags: Utah, cancer research, University of Utah Salt Lake City, Univ of Utah, sarcomagenesis, Jones Lab

New Research Facility Opens at USC Keck School

Posted by Gloria Beverage on Thu, Dec 06, 2018

USC recently opened the USC Stevens Hall for Neuroimaging, the new home for the Mark and Mary Stevens Neuroimaging and Informatics Institute. The sleek, modern, state-of-the-art research building is located on the southern edge of USC's Health Sciences Campus and will help accelerate research on neurological disorders such as autism and Alzheimer’s Disease.

Read More

Tags: CA, University of Southern California, new research building, New research facilities, California, USC, Southwest Region, New research center, Neuroradiology, Neurological Research

Duke: Researchers find how Natural Killer Cells Regulate Protective HIV Antibodies

Posted by Andrea Inks on Tue, Dec 04, 2018

Duke received a $28 Million grant from the NIH to discover immunologic research directed at tackling major scientific problems that hinder the development of an effective HIV-1 vaccine. The vaccine strategy will be based on identifying and targeting novel HIV-1 vulnerabilities to B, T and NK cell immune responses and then using this information to design vaccines that will induce protective immunity at the time and location of HIV-1 transmission.

Read More

Tags: Duke University, duke medicine, HIV Vaccine, HIV research

Connect With Us   Like Us on Facebook   Follow Us on Twitter   See our latest photos!   Join Us on Google +   Find Us on LinkedIn   Pin our latest stories!

Subscribe to Company News